Live Breaking News & Updates on Brainstorm cell therapeutics inc

Stay informed with the latest breaking news from Brainstorm cell therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Brainstorm cell therapeutics inc and stay connected to the pulse of your community

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,990,000 shares, an increase of 48.5% from the March 31st total of 1,340,000 shares. Based on an average daily volume of 987,100 shares, the short-interest […]

Securities-exchange-commission , Brainstorm-cell-therapeutics-inc , Nasdaq , Kingswood-wealth-advisors , Brainstorm-cell-therapeutics , Get-free-report , Cell-therapeutics , Brainstorm-cell , Wealth-advisors , Free-report , Cell-therapeutics-inc

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

NEW YORK, April 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced that it received a notification...

California , United-states , Michael-wood , Prnewswire-brainstorm-cell-therapeutics-inc , National-ms-society , Brainstorm-cell-therapeutics-inc , Nasdaq , European-medicines-agency , Listing-qualifications-department , Drug-administration , California-institute-for-regenerative-medicine , Storm-cell-therapeutics

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University-of-california-irvine , California , United-states , Massachusetts , University-of-massachusetts , Lisa-guiterman , Anthonyj-windebank , Stacy-lindborg , Robertj-manning , Michael-wood , Julieanne-doran , Jean-pape-adams

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Lisa-guiterman , Chaim-lebovits , Stacy-lindborg , Michael-wood , California-institute-for-regenerative-medicine , Prnewswire-brainstorm-cell-therapeutics-inc , National-ms-society , Drug-administration , Data-monitoring-committee , Nasdaq

Brainstorm Cell Therapeutics (BCLI) Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Brainstorm Cell Therapeutics (BCLI) Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stacy-lindborg , Chaim-lebovits , Data-monitoring-committee , Drug-administration , Nasdaq , Brainstorm-cell-therapeutics-inc , Brainstorm-cell-therapeutics , Special-protocol-assessment , Biologics-license-application , Chief-executive-officer , Institutional-review-board ,

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket - Biophytis (NASDAQ:BPTS)

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Tuanche-limited , Anghami-inc , Digiasia-corp , Mymd-pharmaceuticals-inc , Biosig-technologies-inc , Hanryu-holdings-inc , Maxeon-solar-technologies-ltd , Brainstorm-cell-therapeutics-inc , Utime-limited , Vaccines-inc , Halozyme-therapeutics-inc

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

A conference call and webcast will be held Tomorrow, April 9, at 8:00 a.m. Eastern Time
NEW YORK, April 8, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of cellular...

California , United-states , Michael-wood , Chaim-lebovits , Stacy-lindborg , Bob-dagher , Prnewswire-brainstorm-cell-therapeutics-inc , European-medicines-agency , National-ms-society , Nasdaq , Drug-administration , Brainstorm-cell-therapeutics-inc

BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

California , United-states , Michael-wood , Lisa-guiterman , Chaim-lebovits , Bob-dagher , Stacy-lindborg , Dennis-riedl , Brainstorm-cell-therapeutics-inc , Gene-therapies-advisory-committee , Research-symposium , Drug-administration

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

Conference call planned for early April 2024 to provide update on NurOwn program
NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell...

California , United-states , Stacy-lindborg , Chaim-lebovits , Lisa-guiterman , Michael-wood , Research-symposium , Drug-administration , European-medicines-agency , California-institute-for-regenerative-medicine , Nasdaq , National-ms-society

Brainstorm Cell Therapeutics Announces Full Year 2023 Financial Results And Provides Corporate Update

Brainstorm Cell Therapeutics Announces Full Year 2023 Financial Results And Provides Corporate Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Chaim-lebovits , Stacy-lindborg , Michael-wood , Lisa-guiterman , Nasdaq , European-medicines-agency , Research-symposium , National-ms-society , California-institute-for-regenerative-medicine , Gene-therapies-advisory-committee